ZYME FY 2020 Earnings — Zymeworks Inc. Revenue & Financial Results | Market Cap Arena

ZYMEZymeworks Inc.

$2B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$39M+31.8% YoY

Gross Profit

-$132M-338.7% margin

Operating Income

-$187M-481.3% margin

Net Income

-$181M-463.5% margin

EPS (Diluted)

$-3.58

Cash Flow

Operating Cash Flow

-$151M

Free Cash Flow

-$158M

Stock-Based Comp.

$29M

Balance Sheet

Total Assets

$538M

Total Liabilities

$128M

Stockholders' Equity

$410M

Cash & Equivalents

$242M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$39M	$30M	+31.8%
Gross Profit	-$132M	-$88M	-50.7%
Operating Income	-$187M	-$151M	-23.9%
Net Income	-$181M	-$145M	-24.1%